345 related articles for article (PubMed ID: 6638150)
1. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study.
Lloyd RV
Am J Pathol; 1983 Nov; 113(2):198-206. PubMed ID: 6638150
[TBL] [Abstract][Full Text] [Related]
2. Effects of diethylstilbestrol and propylthiouracil on the rat pituitary. An immunohistochemical and ultrastructural study.
Lloyd RV; Mailloux J
J Natl Cancer Inst; 1987 Oct; 79(4):865-73. PubMed ID: 3477666
[TBL] [Abstract][Full Text] [Related]
3. Analysis of prolactin and growth hormone production in hyperplastic and neoplastic rat pituitary tissues by the hemolytic plaque assay.
Lloyd RV; Coleman K; Fields K; Nath V
Cancer Res; 1987 Feb; 47(4):1087-92. PubMed ID: 3542200
[TBL] [Abstract][Full Text] [Related]
4. Effects of pergolide on diethylstilbestrol-induced rat pituitary hyperplasia.
Lloyd RV; Schmidt K; Nath V
Am J Pathol; 1985 Dec; 121(3):486-95. PubMed ID: 4073221
[TBL] [Abstract][Full Text] [Related]
5. Effects of estrogen and tamoxifen on the ultrastructural characteristics of female rat prolactin cells as evaluated by immunogold technique.
Erensoy N; Cagatay P; Yilmazer S
Acta Histochem; 2005; 107(3):199-205. PubMed ID: 15993477
[TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
7. Glandular kallikrein in estrogen-induced pituitary tumors: time course of induction and correlation with prolactin.
Hatala MA; Powers CA
Cancer Res; 1988 Aug; 48(15):4158-62. PubMed ID: 3390808
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
[TBL] [Abstract][Full Text] [Related]
9. Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen.
Gómez O; Balsa JA
Endocrinology; 2003 Oct; 144(10):4403-9. PubMed ID: 12960047
[TBL] [Abstract][Full Text] [Related]
10. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
Pisarek H; Stepien H; Pawlikowski M
Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
[TBL] [Abstract][Full Text] [Related]
11. [Morphological studies on estrogen-induced PRL cell hyperplasia in rat pituitary gland--immunocytochemical and scanning electron microscopic studies].
Inagaki H; Hori T
No To Shinkei; 1989 Jun; 41(6):593-601. PubMed ID: 2803826
[TBL] [Abstract][Full Text] [Related]
12. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
Winneker RC; Parsons JA
Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
[TBL] [Abstract][Full Text] [Related]
13. Estrogen increases galanin immunoreactivity in hyperplastic prolactin-secreting cells in Fisher 344 rats.
Hsu DW; el-Azouzi M; Black PM; Chin WW; Hedley-Whyte ET; Kaplan LM
Endocrinology; 1990 Jun; 126(6):3159-67. PubMed ID: 1693569
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and ultrastructural studies on estrogen-induced pituitary tumors in F344 rats.
De Nicola AF; von Lawzewitsch I; Kaplan SE; Libertun C
J Natl Cancer Inst; 1978 Sep; 61(3):753-63. PubMed ID: 278852
[TBL] [Abstract][Full Text] [Related]
15. Effects of estrogen and dexamethasone on a transgenic pituitary cell line. Regulation of hormone and chromogranin/secretogranin expression.
Thiny MT; Antczak C; Fields K; Jin L; Lloyd RV
Lab Invest; 1994 Jun; 70(6):899-906. PubMed ID: 7912292
[TBL] [Abstract][Full Text] [Related]
16. The effects of estradiol on prolactin and growth hormone secretion in cultured pituitary cells from intact and ovariectomized rats.
Komolov IS; Perez-Arce JA; Fedotov VP
Endokrinologie; 1980 Jun; 75(3):278-84. PubMed ID: 7428709
[TBL] [Abstract][Full Text] [Related]
17. Time course of induction of prolactin-secreting pituitary tumors with diethylstilbestrol in male rats: response of tuberoinfundibular dopaminergic neurons.
Morgan WW; Steger RW; Smith MS; Bartke A; Sweeney CA
Endocrinology; 1985 Jan; 116(1):17-24. PubMed ID: 3917247
[TBL] [Abstract][Full Text] [Related]
18. Release of prolactin and growth-hormone by pituitary grafts. Role of the neurointermediate lobe.
Settembrini BP; Gallardo MG; Tramezzani JH
Acta Physiol Pharmacol Ther Latinoam; 1991; 41(3):337-47. PubMed ID: 1843868
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone, PPAR-gamma receptor ligand, decreases the viability of rat prolactin-secreting pituitary tumor cells in vitro.
Gruszka A; Kunert-Radek J; Pawlikowski M
Neuro Endocrinol Lett; 2005 Feb; 26(1):51-4. PubMed ID: 15726020
[TBL] [Abstract][Full Text] [Related]
20. Estrogen induction of prolactin-producing pituitary tumors in the Fischer 344 rat: modulation by dietary-energy but not protein consumption.
Shull JD; Birt DF; McComb RD; Spady TJ; Pennington KL; Shaw-Bruha CM
Mol Carcinog; 1998 Oct; 23(2):96-105. PubMed ID: 9808163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
